Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
SSBP1 mutations cause mtDNA depletion underlying a complex optic atrophy disorder
Valentina Del Dotto, … , Tommaso Pippucci, Valerio Carelli
Valentina Del Dotto, … , Tommaso Pippucci, Valerio Carelli
Published September 24, 2019
Citation Information: J Clin Invest. 2020;130(1):108-125. https://doi.org/10.1172/JCI128514.
View: Text | PDF
Research Article Genetics Ophthalmology Article has an altmetric score of 6

SSBP1 mutations cause mtDNA depletion underlying a complex optic atrophy disorder

  • Text
  • PDF
Abstract

Inherited optic neuropathies include complex phenotypes, mostly driven by mitochondrial dysfunction. We report an optic atrophy spectrum disorder, including retinal macular dystrophy and kidney insufficiency leading to transplantation, associated with mitochondrial DNA (mtDNA) depletion without accumulation of multiple deletions. By whole-exome sequencing, we identified mutations affecting the mitochondrial single-strand binding protein (SSBP1) in 4 families with dominant and 1 with recessive inheritance. We show that SSBP1 mutations in patient-derived fibroblasts variably affect the amount of SSBP1 protein and alter multimer formation, but not the binding to ssDNA. SSBP1 mutations impaired mtDNA, nucleoids, and 7S-DNA amounts as well as mtDNA replication, affecting replisome machinery. The variable mtDNA depletion in cells was reflected in severity of mitochondrial dysfunction, including respiratory efficiency, OXPHOS subunits, and complex amount and assembly. mtDNA depletion and cytochrome c oxidase–negative cells were found ex vivo in biopsies of affected tissues, such as kidney and skeletal muscle. Reduced efficiency of mtDNA replication was also reproduced in vitro, confirming the pathogenic mechanism. Furthermore, ssbp1 suppression in zebrafish induced signs of nephropathy and reduced optic nerve size, the latter phenotype complemented by WT mRNA but not by SSBP1 mutant transcripts. This previously unrecognized disease of mtDNA maintenance implicates SSBP1 mutations as a cause of human pathology.

Authors

Valentina Del Dotto, Farid Ullah, Ivano Di Meo, Pamela Magini, Mirjana Gusic, Alessandra Maresca, Leonardo Caporali, Flavia Palombo, Francesca Tagliavini, Evan Harris Baugh, Bertil Macao, Zsolt Szilagyi, Camille Peron, Margaret A. Gustafson, Kamal Khan, Chiara La Morgia, Piero Barboni, Michele Carbonelli, Maria Lucia Valentino, Rocco Liguori, Vandana Shashi, Jennifer Sullivan, Shashi Nagaraj, Mays El-Dairi, Alessandro Iannaccone, Ioana Cutcutache, Enrico Bertini, Rosalba Carrozzo, Francesco Emma, Francesca Diomedi-Camassei, Claudia Zanna, Martin Armstrong, Matthew Page, Nicholas Stong, Sylvia Boesch, Robert Kopajtich, Saskia Wortmann, Wolfgang Sperl, Erica E. Davis, William C. Copeland, Marco Seri, Maria Falkenberg, Holger Prokisch, Nicholas Katsanis, Valeria Tiranti, Tommaso Pippucci, Valerio Carelli

×

Figure 5

Effect of SSBP1 mutations on protein stability, oligomerization, and ssDNA binding in fibroblasts.

Options: View larger image (or click on image) Download as PowerPoint
Effect of SSBP1 mutations on protein stability, oligomerization, and ssD...
(A) Western blot analysis of SSBP1 expression levels on isolated mitochondria; VDAC1 was used as a loading control. A representative blot out of 4 independent experiments is shown. (B) Densitometric analysis of 4 independent Western blot experiments shows an increase and a reduction of SSBP1 levels in G40V and I132V cells, respectively. All values (mean ± SD) are normalized to control cells. n = 12 (controls) and 4 (mutants). *P < 0.05; ***P < 0.001. Statistical significance was determined using 1-way ANOVA with Tukey’s correction.(C) Representative confocal images of fibroblasts labeled with anti-SSBP1 antibody (green) and MitoTracker red (red). Boxes on merged images correspond to magnified insets at right of each panel. Scale bar: 10 μm. (D) Quantification of SSBP1-MitoTracker colocalization, expressed as corrected total cell fluorescence (CTCF) ratio on 9 images per group. Data are represented as mean ± SD. (E) SSBP1 oligomerization analysis performed on the same samples used in A. GA: 0.1% GA. The presence of monomeric (molecular weight around 15 kDa), dimeric (molecular weight around 30 kDa), trimeric (molecular weight around 45 kDa), and multimeric (molecular weights > 60 kDa) forms are indicated. The protein amount utilized for the different samples was previously determined for Western blot analysis in Figure 3A. (F) Densitometric analysis of E shows that p.R107Q and p.I132V mutations, but not p.G40V, interfere with SSBP1 multimerization. All values represent the ratio between each oligomer amount in the presence of GA and monomers without GA. (G) SSBP1-ssDNA binding assay performed on isolated mitochondria shows that SSBP1 mutants were able to bind ssDNA. Streptavidin-agarose beads were used to precipitate biotinylated ssDNA together with associated proteins. Supernatants and pull-down fractions were run on a SDS-PAGE and immunoblotted with anti-SSBP1, anti-VDAC1, anti-HSP60, and anti-ETHE1 antibodies. A representative blot out of 3 is shown. *P < 0.05; ***P < 0.001. Statistical significance was determined using 1-way ANOVA with Tukey’s correction.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 5 X users
Referenced in 1 patents
On 1 Facebook pages
78 readers on Mendeley
See more details